This paper presents three case studies involving chronic gastrointestinal and genitourinary conditions. The first case examines a 46-year-old male diagnosed with gastroesophageal reflux disease (GERD), covering differential diagnoses, upper endoscopy workup, proton pump inhibitor therapy, and lifestyle modifications. The second case analyzes a 27-year-old female diagnosed with irritable bowel syndrome (IBS), applying Rome criteria and addressing stress- and diet-related triggers alongside pharmacological options. The third case evaluates a 65-year-old male with benign prostatic hyperplasia (BPH), detailing combination drug therapy with finasteride and tamsulosin and relevant patient education strategies. Each scenario integrates clinical reasoning, diagnostic testing rationale, and both pharmacological and nonpharmacological treatment approaches.
The primary diagnosis in this scenario is gastroesophageal reflux disease (GERD). This diagnosis is based on the strength of the presenting symptoms. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, 2014), symptoms associated with GERD include "regular heartburn, a painful, burning feeling in the middle of your chest, behind your breastbone, and in the middle of your abdomen." The 46-year-old male in this case presents those very same symptoms. In essence, the patient's symptoms result from the backflow of stomach contents into his esophagus. Given that this has been occurring over the past couple of months, the lining of his esophagus is irritated, hence the need for immediate medical attention to ease symptoms.
The differential diagnosis in this scenario is peptic ulcer disease — specifically gastric ulcers, which are open sores on the stomach's inner lining. A person suffering from gastric ulcers is likely to experience discomfort in the middle of the abdomen described as a burning sensation. The differential diagnosis could also include gastroparesis, dyspepsia, and gastritis.
To confirm the primary diagnosis, additional diagnostic testing is warranted. An upper endoscopy would be useful for examining the 46-year-old's esophagus and stomach. In the case of GERD, this procedure would most likely reveal esophagitis. Upper endoscopy also permits biopsy, in which case the collected tissue could be assessed further — for example, for Barrett's esophagus. Other diagnostic procedures to consider include an upper digestive system X-ray and esophageal manometry.
Treatment in this case would include both pharmacological and nonpharmacological interventions. The most appropriate pharmacological intervention is a drug to block acid production. This is especially relevant given that the patient has been experiencing symptoms for several months and reports that his mid-chest pain has worsened over the past few weeks. Blocking acid production is necessary to allow the esophagus to heal. Proton pump inhibitors (PPIs) would be effective for this purpose; specifically, omeprazole (Zegerid OTC) would be appropriate. Additionally, Baclofen could be considered for its ability to strengthen the lower esophageal sphincter. If medications prove ineffective, surgery — specifically fundoplication — would be considered.
The patient would also need to make lifestyle modifications to reduce acid reflux frequency. The examination reveals that the patient is obese. Weight loss would be beneficial, as excess abdominal pressure can push up an obese individual's stomach and trigger reflux (Fisichella, Allaix, Morino, & Patti, 2014). Dietary modifications are also necessary, as reflux can be triggered by caffeine, chocolate, alcohol, onions, garlic, and fried or fatty foods (Fisichella, Allaix, Morino, & Patti, 2014).
The primary diagnosis in this scenario is irritable bowel syndrome (IBS). According to the NIDDK (2019), "the most common symptoms of irritable bowel syndrome (IBS) are pain in your abdomen, often related to your bowel movements, and changes in your bowel movements." The patient in this case presents symptoms consistent with IBS, including lower-left abdominal pain related to frequent and urgent bowel movements.
According to Lacy and Patel (2017), known triggers of IBS include hormones, stress, and food. The 27-year-old female reports considerable work-related stress and a recent breakup, and the associated stress may have triggered her IBS symptoms. It is also notable that certain beverages and foods are known to worsen IBS symptoms; the patient reports that her symptoms worsen following consumption of dairy products or fried foods.
The differential diagnosis in this scenario includes diverticular disease, carcinoid tumor, and celiac disease. To confirm the primary diagnosis, diagnostic criteria including the Manning criteria and Rome criteria would be applied, given that IBS cannot be definitively diagnosed with a single test. As per the Rome criteria, Lacy and Patel (2017) note that "disordered bowel habits are typically present (i.e., constipation, diarrhea, or a mix of constipation and diarrhea), as are symptoms of abdominal bloating/distension. Symptom onset should occur at least 6 months prior to diagnosis and symptoms should be present during the last 3 months" (p. 97). To rule out other conditions, a CT scan, colonoscopy, or flexible sigmoidoscopy may be necessary. Given the patient's report that dairy products worsen her symptoms, a lactose intolerance test should also be considered.
Treatment would focus on relieving the presenting symptoms with the goal of restoring normal functioning. Medications to be considered include Eluxadoline (Viberzi) and Alosetron (Lotronex). Nonpharmacological interventions would include stress management strategies and avoidance of trigger foods such as dairy products and fried foods.
"BPH diagnosis, combination drug therapy, patient education"
Each of these three cases illustrates how chronic GI and GU conditions require careful integration of patient history, evidence-based diagnostic criteria, and individualized treatment planning. GERD, IBS, and BPH each present with overlapping symptom profiles that necessitate systematic differential diagnosis. Effective management in all three scenarios combines targeted pharmacological therapy with nonpharmacological strategies tailored to the patient's specific lifestyle, comorbidities, and triggers.
You’re 66% through this paper. Sign up to read the remaining 1 section.
Sign Up Now — Instant Access Already a member? Log inAlways verify citation format against your institution’s current style guide requirements.